Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Texas OK’s $50 Million for Ibogaine Research

The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.

Andrew Jacobs
Author: Andrew Jacobs

Written by

Andrew Jacobs

in

Clinical Trials, Depression (Mental), Drugs (Pharmaceuticals), Food and Drug Administration, Ibogaine (drug), Law and Legislation, Mental Health and Disorders, Opioids and Opiates, Psychedelic and Hallucinogenic Drugs, Psychiatry and Psychiatrists, Regulation and Deregulation of Industry, Research, Texas, Therapy and Rehabilitation, Traumatic Brain Injury, United States Politics and Government, Veterans
←At a Fatherhood Summit, Dads Wonder: How Should a Modern-Day Father Be?
Inside Universal’s Big Bet on ‘How to Train Your Dragon’→

More posts

  • Australia’s Chaudhary downs England in tetchy first T20

  • Zelensky says Crimean Bridge strikes ‘fair response’ as he meets UK’s Streeting

  • What “Looney Tunes” Villain Are You?

  • Is Raphael Warnock running for president?

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube